Achieve Life Sciences (ACHV) Change in Cash (2010 - 2026)
Achieve Life Sciences (ACHV) posted Change in Cash of $7.4 million for Q1 2026, up 166.94% on a QoQ basis from -$11.0 million in Q4 2025, and up 2700.0% year-over-year from $263000.0 in Q1 2025.
Achieve Life Sciences (ACHV) Change in Cash (2010 - 2026) Analysis & Trends
Achieve Life Sciences' Change in Cash history runs 17 years deep, the most recent figure standing at $7.4 million for Q1 2026.
- Quarterly Change in Cash rose 2700.0% year-over-year to $7.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $15.3 million (up 128.62% YoY) and the FY2025 annual result came in at $8.2 million, up 389.62% from the prior year.
- Change in Cash was $7.4 million for Q1 2026 at Achieve Life Sciences, up from -$11.0 million in the prior quarter.
- Across five years, Change in Cash topped out at $50.8 million in Q1 2024 and bottomed at -$51.6 million in Q2 2024.
- A 5-year average of -$868176.5 and a median of -$5.2 million in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash tumbled 703.51% — and 2026, when it soared 2700.0%.
- Achieve Life Sciences' Change in Cash stood at $6.6 million in 2022, then plunged by 166.52% to -$4.4 million in 2023, then soared by 173.38% to $3.2 million in 2024, then slumped by 442.82% to -$11.0 million in 2025, then jumped by 166.94% to $7.4 million in 2026.
- Business Quant data shows ACHV's Change in Cash at $7.4 million in Q1 2026, -$11.0 million in Q4 2025, and -$19.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 243.78 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 57.19 Mn |
| 10 | Achieve Life Sciences | 326.16 Mn | 326.16 Mn | - | 7.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.36 Mn |
| Dec 31, 2025 | -11.00 Mn |
| Sep 30, 2025 | -19.94 Mn |
| Jun 30, 2025 | 38.86 Mn |
| Mar 31, 2025 | 263,000.00 |
| Dec 31, 2024 | 3.21 Mn |
| Sep 30, 2024 | -5.21 Mn |
| Jun 30, 2024 | -51.64 Mn |
| Mar 31, 2024 | 50.82 Mn |
| Dec 31, 2023 | -4.37 Mn |
| Sep 30, 2023 | -5.15 Mn |
| Jun 30, 2023 | 8.56 Mn |
| Mar 31, 2023 | -8.26 Mn |
| Dec 31, 2022 | 6.57 Mn |
| Sep 30, 2022 | -11.18 Mn |
| Jun 30, 2022 | -6.96 Mn |
| Mar 31, 2022 | -6.69 Mn |
| Dec 31, 2021 | 9.71 Mn |
| Sep 30, 2021 | -8.69 Mn |
| Jun 30, 2021 | 12.36 Mn |